Clinical Trial: A Study of Asciminib Safety and Efficacy in Young Adults With Chronic Myeloid Leukemia in the Gulf Region

U.S., July 3 -- ClinicalTrials.gov registry received information related to the study (NCT07681258) titled 'A Study of Asciminib Safety and Efficacy in Young Adults With Chronic Myeloid Leukemia in the Gulf Region' on June 26.

Brief Summary: The aim of this study is to evaluate the real-world effectiveness and safety of asciminib among young adults with chronic myeloid leukemia (CML) across the Gulf region. The data source for this study will consist of routinely collected clinical information documented within the electronic health records (EHR) of participating centers.

Study Start Date: June 30

Study Type: OBSERVATIONAL

Condition: Chronic Myeloid Leukemia

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Novartis Pharmaceuticals

Di...